Evidence map›Paper›PMID 24793544›Full record

ReviewJournal of clinical immunology2014

The long elusive IgM Fc receptor, FcμR.

Hiromi Kubagawa, Satoshi Oka, Yoshiki Kubagawa, Ikuko Torii, Eiji Takayama, Dong-Won Kang, Dewitt Jones, Naonori Nishida, Toshio Miyawaki, Luigi F Bertoli and 2 more

Open access · greenAbstract readReview
In one paragraph

Review in Journal of clinical immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. CD5L is a canonical component of circulatory IgM.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  5. Structural basis for Fc receptor recognition of immunoglobulin M.Nature structural & molecular biology · 2023
    Article
  6. Review
  7. Immunoglobulin M-degrading enzyme ofFrontiers in immunology · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Differences between Human and Mouse IgM Fc Receptor (FcµR).International journal of molecular sciences · 2021
    Article
  13. Mapping of the binding site for FcμR in human IgM-Fc.Biochimica et biophysica acta. Proteins and proteomics · 2020
    Article
  14. Secreted IgM: New tricks for an old molecule.Journal of leukocyte biology · 2019
    Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Antibody Isotypes for Tumor Immunotherapy.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2017
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Hiromi KubagawaDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL, 35209, USA, hiromikubagawa@uab.edu.
Satoshi Oka
Yoshiki Kubagawa
Ikuko Torii
Eiji Takayama
Dong-Won Kang
Dewitt Jones
Naonori Nishida
Toshio Miyawaki
Luigi F Bertoli
Sheila K Sanders
Kazuhito Honjo
University of Alabama at Birmingham · USUniversity of Toyama · JPHyogo Medical University · JP

Funding

Structure and Function of an Fc Receptor for IgA and IgMR01AI052243 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KUBAGAWA, HIROMI · 2004 to 2008
$1.4M
Imaging biomaterial-associated inflammationR21AI094624 · NIAID · GEORGIA INSTITUTE OF TECHNOLOGY · PI GARCIA, ANDRES J · 2011 to 2012
$414k
IgM Fc receptor in CLLR21AI094625 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KUBAGAWA, HIROMI · 2012 to 2013
$403k
Studies of structure and function of an Fc receptor for IgMR56AI082249 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KUBAGAWA, HIROMI · 2010 to 2010
$349k
NIAID NIH HHS AI52243NIAID NIH HHS R01 AI052243NIAID NIH HHS R21 AI094624NIAID NIH HHS R21 AI094625NIAID NIH HHS R21AI94624NIAID NIH HHS R56 AI082249NIAID NIH HHS R56AI82249
6 · The paper itself

Abstract

IgM exists as both a monomer on the surface of B cells and a pentamer secreted by plasma cells. Both pre-immune "natural" and antigen-induced "immune" IgM antibodies are important for protective immunity and for immune regulation of autoimmune processes by recognizing pathogens and self-antigens. Effector proteins interacting with the Fc portion of IgM, such as complement and complement receptors, have thus far been proposed but fail to fully account for the IgM-mediated protection and regulation. A major reason for this deficit in our understanding of IgM function seems to be lack of data on a long elusive Fc receptor for IgM (FcμR). We have recently identified a bona fide FcμR in both humans and mice. In this article we briefly review what we have learned so far about FcμR.

Indexed as

AnimalsAutoantigensB-LymphocytesHumansImmunoglobulin MImmunomodulationMiceReceptors, FcAutoantigensImmunoglobulin Mimmunoglobulin M receptorReceptors, Fc

Identifiers

PMID24793544
PMCPMC4160156
OpenAlexW2024774586

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.